NCT03437382View on ClinicalTrials.gov

Holmium Radioembolization as Adjuvant Treatment to RFA for Early Stage HCC: Dose Finding Study

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

March 17, 2021

Study Completion Date

March 17, 2021

Conditions
HCCEarly Stage HCC
Interventions
DEVICE

Quirem Medical Holmium-166 radioembolization microspheres

radioembolisation as adjuvant treatment to RFA

Trial Locations (1)

2333ZA

Leiden University Medical Center, Leiden

Sponsors

Collaborators (2)

Health Holland
Medtronic
All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

collaborator

Health Holland

OTHER

collaborator

Quirem Medical B.V.

INDUSTRY

collaborator

Medtronic

INDUSTRY

collaborator

Maag Lever Darm Stichting

OTHER

lead

Leiden University Medical Center

OTHER